Resection limit status in the untreated and treated patients with clinical stage C disease
| Surgery only (%) | 12 weeks of NHT (%) | 24 weeks of NHT (%) | |
|---|---|---|---|
| Chi square=13.603; p=0.001. Untreated versus 12 weeks of NHT: χ2=9.402; p=0.002. Untreated versus 24 weeks of NHT: χ2=8.306; p=0.004; 12 weeks of NHT versus 24 weeks of NHT: χ2=0.025; p=0.875 (not significant). | |||
| NHT, neoadjuvant hormonal treatment. | |||
| Negative margins | 7 (24.1%) | 23 (65.7%) | 20 (64.5%) |
| Positive margins | 22 (75.9%) | 12 (34.3%) | 11 (35.5%) |